Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Virchows Arch ; 430(2): 139-48, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9083517

ABSTRACT

Pseudo-Gaucher cells (PGC) are a characteristic finding in Ph-positive CML, and prolongation of survival was observed when PGC were detected within the bone marrow. However, the conspicuous variation in the reported frequencies indicates the necessity for analysis of their natural occurrence in the bone marrow from untreated CML patients. A total of 833 diagnostic bone marrow biopsies from patients with Ph-positive CML were examined for PGC by 7 observers. Proof of PGC was based on systematic examination of Giemsa-stained slides with and without polarization at high magnification. Birefringence within the cytoplasm turned out to be highly specific for PGC. The risk of overlooking PGC was at least 80% when the number of these storing histiocytes was 70 per slide or less, and at least 50% when the total amount per slide was < or = 250. This high risk of failure explained the disagreement among the authors. An intensive investigation by at least two observers is mandatory if results are to be evaluated in research. Under the conditions used in this study, the natural frequency of PGC within the bone marrow from untreated patients with a Ph-positive CML is much higher than assumed to date, amounting to about 70%. On the basis of these findings, the prognostic importance of PGC in CML must be evaluated critically.


Subject(s)
Bone Marrow/pathology , Gaucher Disease/pathology , Histiocytes/pathology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Adult , Biopsy , Chi-Square Distribution , Diagnostic Errors , Humans , Male , Observer Variation , Paraffin Embedding , Plastic Embedding , Reproducibility of Results , Retrospective Studies , Risk Assessment , Sensitivity and Specificity , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL
...